LivaNova PLC (LIVN) stock
LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3032% above fair value
$94.54+2.62 (+2.85%)
Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –
LivaNova total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
LivaNova's total debt was $293.49M at Jun 30, 2026. For fiscal 2025 it was $376.66M, down 40.0% from the year before. The highest annual figure on record is $655.64M in fiscal 2020.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $376.66M | -40.0% |
| FY2024 | Dec 31, 2024 | $627.63M | +7.0% |
| FY2023 | Dec 31, 2023 | $586.65M | +8.3% |
| FY2022 | Dec 31, 2022 | $541.50M | +126.1% |
| FY2021 | Dec 31, 2021 | $239.52M | -63.5% |
| FY2020 | Dec 31, 2020 | $655.64M | +94.1% |
| FY2019 | Dec 31, 2019 | $337.73M | +100.6% |
| FY2018 | Dec 31, 2018 | $168.33M | +15.3% |
| FY2017 | Dec 31, 2017 | $145.99M | – |
| FY2015 | Apr 24, 2015 | $0 | – |
| FY2014 | Apr 25, 2014 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $293.49M | -31.8% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $287.79M | -54.2% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $376.66M | -40.0% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $434.47M | -30.6% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $430.62M | -31.1% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $628.79M | +0.7% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $627.63M | +7.0% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $626.24M | +6.6% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $625.17M | +6.5% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $624.46M | +15.1% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $586.65M | +8.3% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $587.19M | +8.8% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $587.03M | +26.0% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $542.50M | +17.8% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $541.50M | +126.1% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $539.94M | +126.3% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $466.03M | -29.7% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $460.56M | -30.0% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $239.52M | -63.5% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $238.57M | -63.4% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $663.05M | +2.5% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $658.16M | +22.1% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $655.64M | +94.1% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $651.06M | +90.6% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $646.64M | +204.9% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $538.88M | +197.2% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $337.73M | +100.6% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $341.66M | +117.5% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $212.10M | +31.7% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $181.29M | -1.1% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $168.33M | +15.3% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $157.07M | +26.7% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $161.00M | +28.3% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $183.36M | +50.9% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $145.99M | – |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $123.93M | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | $125.52M | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $121.52M | – |
| Q4 FY2015CQ1 2015 | Apr 24, 2015 | $0 | – |
See a number that looks wrong?